The DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.
Effect of Interferon-α on cognitive functioning in patients with chronic hepatitis C
Abstract
Treatment with interferon-alpha (IFN-α) has been shown to adversely affect cognitive functioning in patients with a variety of medical disorders, but information about the effects of IFN-α on cognitive functioning in patients with chronic hepatitis C (CHC) is limited. The purpose of this study was to examine the effects of IFN-α on neuropsychological test performance in CHC patients. Participants were 30 patients with CHC, 11 who underwent IFN-α therapy and 19 who did not. All participants were tested at baseline (i.e., pretreatment) and approximately 6 months later with the Symbol Digit Modalities Test and Trail Making Test. Results revealed that the treatment group performed significantly worse than untreated CHC patients on Part B of the Trail Making Test after approximately 6 months of treatment. No significant group differences were found on Part A of the Trail Making Test or Symbol Digit Modalities Test. Findings suggest that CHC patients undergoing treatment with IFN-α may experience reduced abilities to benefit from practice but suffer no decrements in performance after 6 months of treatment. Additional research is needed to replicate these findings and to explore risk factors for susceptibility to IFN-α-induced effects. (JINS, 2005,11, 16–22.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“hepatitis C patients who received 6 months of IFN-α performed significantly worse on the TMT part B when compared with hepatitis C patients who did not undergo IFN-α treatment (Hilsabeck et al., 2005)”
From The role of inflammation in core features of depression: Insights from paradigms using exogenously-induced inflammation. (2018) · cites this paper as Hilsabeck et al., 2005
Citations
Cites
(1992) · PubMed · Cited by 33,716
The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
Ware, J. E., & Sherbourne, C. D. (1992) · Medical Care · doi:10.1097/00005650-199206000-00002 · Cited by 30,033
MCHORNEY, C. A., JOHNE, W., & ANASTASIAE, R. (1993) · Medical Care · doi:10.1097/00005650-199303000-00006 · Cited by 6,681
McHorney, C. A., Ware, J. E., Rachel Lu, J. F., & Sherbourne, C. D. (1994) · Medical Care · doi:10.1097/00005650-199401000-00004 · Cited by 4,458
McHutchison, J. G., Gordon, S. C., Schiff, E. R., Shiffman, M. L., Lee, W. M., Rustgi, V. K., Goodman, Z. D., Ling, M.-H., Cort, S., & Albrecht, J. K. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811193392101 · Cited by 3,457
The Halstead-Reitan neuropsychological test battery: Theory and clinical interpretation
Reitan, R. M., & Wolfson, D. E. (1993) · Medical Entomology and Zoology · Cited by 3,413
Davis, G. L., Esteban, R., Rustgi, V. K., Hoefs, J. C., Gordon, S. C., TREPO, C. G., Shiffman, M. L., Zeuzem, S., Craxı̀, A., Ling, M.-H., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811193392102 · Cited by 1,271
Foster, G. R., Goldin, R. D., & Thomas, H. C. (1998) · Hepatology · doi:10.1002/hep.510270132 · Cited by 559
DIKMEN, S. S., Heaton, R. K., Grant, I., & Temkin, N. R. (1999) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617799544056 · Cited by 473
Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease
Forton, D. M., Thomas, H. C., Murphy, C. A., Allsop, J. M., Foster, G. R., Main, J., Wesnes, K. A., & Taylor-Robinson, S. D. (2002) · Hepatology · doi:10.1053/jhep.2002.30688 · Cited by 450
Research works printed but not linked: 3
- de Boer, A.G. & Breimer, D.D. (1998).Cytokines and blood-brain barrier permeability. In H.S. Sharma & J. Westman (Eds.),Progress in brain research, volume 115 (pp.425–451).New York:Elsevier Science.
- Lezak, M.D. (1995).Neuropsychological Assessment(3rd ed.).New York:Oxford University Press.
- Beck, A.T. , Steer, R.A. , & Brown, G.K. (1996).Beck Depression Inventory–Second Edition: Manual.San Antonio, TX:The Psychological Corporation.
Cited by
Sorted by citations
Anisman, H., Merali, Z., & Hayley, S. P. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.01.004 · Cited by 341
Dooley, L. N., Kuhlman, K. R., Robles, T. F., Eisenberger, N. I., Craske, M. G., & Bower, J. E. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.09.006 · Cited by 176
Cognitive Dysfunction in Chronic Hepatitis C: A Review
Perry, W., Hilsabeck, R. C., & Hassanein, T. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-9896-z · Cited by 148
Self-citationMajer, M., Welberg, L. A. M., Capuron, L., Pagnoni, G., Raison, C. L., & Miller, A. H. (2008) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.12.009 · Cited by 124
Hoyo-Becerra, C., Schlaak, J., & Hermann, D. M. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.06.200 · Cited by 120
Minimal hepatic encephalopathy
Dhiman, R. K., & Chawla, Y. K. (2009) · Indian Journal of Gastroenterology · doi:10.1007/s12664-009-0003-6 · Cited by 107
Moriyama, M., Fukuhara, T., Britschgi, M., He, Y., Narasimhan, R., Villeda, S., Molina, H. D., Huber, B. T., Holers, M., & Wyss‐Coray, T. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.3617-10.2011 · Cited by 94
Neuropsychological Aspects of Coinfection with HIV and Hepatitis C Virus
Hilsabeck, R. C., Castellon, S. A., & Hinkin, C. H. (2005) · Clinical Infectious Diseases · doi:10.1086/429494 · Cited by 73
Self-citationNeurobehavioral effects of interferon therapy
Valentine, A. D., & Meyers, C. A. (2005) · Current Psychiatry Reports · doi:10.1007/s11920-005-0042-3 · Cited by 68
Improvement of Neurocognitive Function in Responders to an Antiviral Therapy for Chronic Hepatitis C
Kraus, M. R., Schäfer, A., Teuber, G., Porst, H., Sprinzl, K., Wollschlaeger, S. W., Keicher, C., & Scheurlen, M. (2013) · Hepatology · doi:10.1002/hep.26229 · Cited by 56
Neuropsychological function in Greek patients with chronic hepatitis C
Karaivazoglou, K., Assimakopoulos, K., Thomopoulos, K., Theocharis, G. J., Messinis, L., Sakellaropoulos, G. C., & Labropoulou‐Karatza, C. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01486.x · Cited by 55
Huckans, M. S., Seelye, A. M., Parcel, T., Mull, L. J., Woodhouse, J., BJORNSON, D., Fuller, B. E., Loftis, J. M., Morasco, B. J., Sasaki, A. W., et al. (2009) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617708090085 · Cited by 53
Huckans, M. S., Fuller, B. E., Wheaton, V. R., Jaehnert, S., Ellis, C. C., Kolessar, M., Kříž, D., Anderson, J. R., Berggren, K., Olavarria, H., et al. (2014) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2014.07.020 · Cited by 45
Neurologic Manifestations of Hepatitis C Virus Infection
Iriana, S., Curry, M. P., & Afdhal, N. H. (2017) · Clinics in Liver Disease · doi:10.1016/j.cld.2017.03.008 · Cited by 41
Quelhas, R., & Lopes, A. (2009) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000358313.06858.ea · Cited by 40
Fontana, R. J., Bieliauskas, L. A., Lindsay, K. L., Back‐Madruga, C., Wright, E. C., Snow, K. K., Lok, A. S. F., Kronfol, Z., & Padmanabhan, L. (2007) · Hepatology · doi:10.1002/hep.21633 · Cited by 38
Cattie, J. E., Letendre, S. L., Woods, S. P., Barakat, F., Perry, W., Cherner, M., Umlauf, A., Franklin, D., Heaton, R. K., Hassanein, T., et al. (2014) · Journal of NeuroVirology · doi:10.1007/s13365-014-0265-3 · Cited by 36
Self-citationRole of paroxetine in interferon-α-induced immune and behavioural changes in male Wistar rats
Myint, A.-M., O’Mahony, S. M., Kubera, M., Kim, Y. K., Kenny, C., Kaim-Basta, A., Steinbusch, H. W. M., & Leonard, B. E. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881107077165 · Cited by 34
Hilsabeck, R. C., Anstead, G. M., Webb, A., Hoyumpa, A., Ingmundson, P. T., Holliday, S., Zhang, Q., Casas, Á., Jovel, M., & Stern, S. L. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.01.017 · Cited by 31
Self-citationCognitive function and endogenous cytokine levels in children with chronic hepatitis C
Faddan, N. H. A., Shehata, G. A., Hafeez, H. A. A. E., Mohamed, A. O., Hassan, H., & Sameea, F. A. E. (2014) · Journal of Viral Hepatitis · doi:10.1111/jvh.12373 · Cited by 23
Pawełczyk, T., Pawełczyk, A. M., Strzelecki, D., & Rabe‐Jabłońska, J. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2008.03.001 · Cited by 17
Fontana, R. J., Bieliauskas, L. A., Back‐Madruga, C., Lindsay, K. L., Litman, H. J., Lok, A. S.-F., & Kronfol, Z. (2010) · The American Journal of Gastroenterology · doi:10.1038/ajg.2010.3 · Cited by 15
The Role of Aging in Alzheimer’s Disease
Kerchner, G. A., & Wyss‐Coray, T. (2015) · Springer eBooks · doi:10.1007/978-3-319-23246-1_7 · Cited by 14
Hassaan, S. H., Darweesh, A. E. D. M., Khalifa, H., Ramadan, H. K., Hassany, S. M., Ahmed, G. K., & Moustafa, E. F. A. (2019) · The International Journal of Psychiatry in Medicine · doi:10.1177/0091217419858277 · Cited by 13
Cognition in hepatitis C patients treated with pegylated interferon
Wobrock, T., Mihm, U., Löhr, C., Hofmann, W., Sarrazin, C., Zeuzem, S., & Falkai, P. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970701714362 · Cited by 13
Antiinfective Agents Affecting Cognition: A Review
Khalifa, A. E. (2007) · Journal of Chemotherapy · doi:10.1179/joc.2007.19.6.620 · Cited by 8
Miller, T. R., Weiss, J. J., Bräu, N., Dieterich, D. T., Stivala, A. C., & Mindt, M. R. (2016) · Journal of NeuroVirology · doi:10.1007/s13365-016-0494-8 · Cited by 8
Cognitive effects of pegylated interferon in individuals with primary brain tumors
Dickinson, M. D., Barr, C. D., Hiscock, M., & Meyers, C. A. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-9920-6 · Cited by 7
Bassiony, M. M., Yousef, A. M., Raya, Y., El-Shabrawi, A., Fouad, E. A., & El-Shafeey, M. (2015) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2015.1064964 · Cited by 6
Beyond the Numbers: Expanding the Boundaries of Neuropsychology
Perry, W. (2009) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acp001 · Cited by 5
Self-citationA Systematic Review on Interferon Alpha-Induced Cognitive Impairment in Hepatitis C Patients
Khan, M. A., Kaushik, P., Agarwal, N. B., & Garg, A. (2022) · Current Drug Safety · doi:10.2174/1574886317666220428134931 · Cited by 3
Yates, S. (2009) · Research Commons (University of Waikato) · Cited by 3
Elsayed, H., Elsayed, M., Arafa, M., & El‐Bendary, M. (2012) · Middle East Current Psychiatry · doi:10.1097/01.xme.0000407891.12614.d0 · Cited by 2
Trastornos psiquiátricos y cognitivos de la hepatitis C y su tratamiento con interferón
Caneo, C., Matías González, T., Repetto, P. B., & Alejandro Soza, R. (2010) · Revista médica de Chile · doi:10.4067/s0034-98872010001200014 · Cited by 2
Borkowska, A., Halota, W., & RYBAKOWSKI, J. K. (2008) · Cited by 2
Thein, H., & Dore, G. J. (2009) · Springer eBooks · doi:10.1007/978-0-387-78665-0_191 · Cited by 1
Boban, M., & Malojčić, B. (2011) · Translational Neuroscience · doi:10.2478/s13380-011-0039-9 · Cited by 1
Neurochemistry immune systems interaction in depression
Myint, A.-M. (2007) · Research Publications (Maastricht University) · doi:10.26481/dis.20070118am · Cited by 1
Alcohol Abuse, HIV-1, and Hepatitis C Infection
Persidsky, Y., Ho, W., Wang, X., & Potula, R. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4729-0_16
ESTUDIO DE LA FUNCIÓN INMUNITARIA EN PACIENTES ESQUIZOFRÉNICOS Y BIPOLARES TIPO I
Santiago, C., & Ma, R. (2007) · TDX (Tesis Doctorals en Xarxa)
Metadata
- Authors
- HILSABECK, R. C., HASSANEIN, T. I., ZIEGLER, E. A., CARLSON, M. D., & PERRY, W.
- Affiliations
- Texas Tech University (US)
- University of California San Diego (US)
- Venue
- Journal of the International Neuropsychological Society
- Publisher
- Cambridge University Press (CUP)
- Published
- 2005-01
- Volume
- 11
- Issue
- 1
- Pages
- 16-22
- ISSN
- 1355-6177 (ISSN-L)
- 1469-7661
- OpenAlex
- W2150327179
- Cited by
- 40
- References
- 55
- Citations by year
- 2022: 1 · 2019: 1 · 2018: 1 · 2017: 1 · 2016: 1 · 2015: 2 · 2014: 4 · 2013: 1 · 2012: 2
- FWCI
- 3.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of the International Neuropsychological Society (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- interferon-alpha, chronic hepatitis C, cognitive function, neuropsychological performance, Trail Making Test, Symbol Digit Modalities Test, practice effects, antiviral therapy adverse effects
- MeSH terms
- Antiviral Agents, Cognition Disorders, Female, Hepatitis C, Humans, Immunologic Factors, Male, Middle Aged, Neuropsychological Tests, Psychomotor Performance, Treatment Outcome, Interferon-alpha
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
